SELL KO x40 — Reduce KO toward target allocation while retaining defensive ballast.
SELL NVDA x1 — Trim NVDA modestly to manage tech concentration and event risk.
SELL RRC — Fully exit RRC due to Energy sector rotation and exclusion from target portfolio.
BUY TSM — Increase TSM to target allocation as a high-conviction Technology holding.
BUY GOOGL — Increase GOOGL to target allocation while maintaining tech risk discipline.
BUY MSFT — Increase MSFT to target allocation as a high-conviction quality growth holding.
BUY WPM — Initiate WPM as approved Materials exposure under risk-on growth regime.
BUY V — Increase V to target allocation for quality payments exposure.
▶WEEK 16May 4$125,738.89
SELL RRC x363 — Trim RRC to target allocation while retaining Energy exposure.
SELL SN — Full exit; SN is not in target portfolio.
SELL TOL — Full exit; TOL is not in target portfolio.
SELL TXN — Full exit; TXN is not in target portfolio.
BUY TSM — Initiate TSM at target allocation.
BUY GOOGL — Initiate GOOGL at target allocation.
BUY NVDA — Initiate NVDA at target allocation.
BUY KO — Initiate KO at target defensive allocation.
BUY MSFT — Initiate MSFT at target allocation.
BUY JNJ — Initiate JNJ at target defensive healthcare allocation.
BUY V — Initiate V at target allocation.
▶WEEK 15Apr 27$127,204.34
SELL GOOG — Full exit because GOOG is not in the target portfolio.
SELL MRK — Full exit because MRK is not in the target portfolio.
SELL MU — Full exit because MU is not in the target portfolio.
SELL NVDA — Full exit because NVDA is not in the target portfolio.
SELL TSM — Full exit because TSM is not in the target portfolio.
BUY SN — Initiate new target position at 21.25% allocation.
BUY RRC — Initiate new target position at 21.25% allocation.
BUY TXN — Initiate new target position at 21.25% allocation.
BUY TOL — Initiate new target position at 21.25% allocation.
▶WEEK 14Apr 20$120,589.89
SELL MRK x49 — Trim MRK by approximately 25% to reduce exposure to a macro-avoided healthcare sector and fund a new TSM position while preserving the 20% cash target.
BUY TSM — Initiate a modest TSM position as the only approved new buy, sized to keep overall invested exposure near 80% and respect current concentration limits.
▶WEEK 13Apr 13$116,224.53
SELL ADBE — Not in target portfolio - full exit
SELL CSCO — Not in target portfolio - full exit
SELL GOOGL — Not in target portfolio - full exit
SELL LRCX — Not in target portfolio - full exit
SELL PANW — Not in target portfolio - full exit
SELL TSM — Not in target portfolio - full exit
SELL V — Not in target portfolio - full exit
BUY NVDA — New position at 20.5%
BUY GOOG — Increasing position from 12.31% to 20.5%
BUY MRK — Increasing position from 11.43% to 20.5%
BUY MU — New position at 20.5%
▶WEEK 12Apr 6$111,658.89
SELL HBM — Not in target portfolio - full exit
SELL MRK x16 — Reducing position from 13.76% to 12%
SELL NEM — Not in target portfolio - full exit
SELL PAAS — Not in target portfolio - full exit
SELL PG — Not in target portfolio - full exit
BUY GOOG — New position at 12%
BUY GOOGL — New position at 12%
BUY TSM — New position at 12%
BUY PANW — New position at 8%
BUY LRCX — New position at 8%
BUY CSCO — New position at 8%
BUY V — New position at 8%
BUY ADBE — New position at 8%
▶WEEK 11Mar 30$107,052.42
SELL COP — Not in target portfolio - full exit
SELL EOG — Not in target portfolio - full exit
SELL KGC — Not in target portfolio - full exit
SELL SLB — Not in target portfolio - full exit
SELL TSM — Not in target portfolio - full exit
BUY MRK — Increasing position from 12.35% to 14%
BUY NEM — New position at 14%
BUY PG — New position at 14%
BUY HBM — New position at 14%
BUY PAAS — New position at 14%
▶WEEK 10Mar 23$104,351.37
SELL NEM — Not in target portfolio - full exit
BUY TSM — New position at 12.5%
BUY MRK — New position at 12.5%
BUY KGC — New position at 12.5%
BUY EOG — New position at 12.5%
BUY SLB — New position at 12.5%
BUY COP — New position at 12.5%
▶WEEK 9Mar 16$108,677.47
BUY NEM — Rebalance NEM from ~39.34% to 40.00% target weight under max-position constraint while maintaining elevated cash buffer per late-cycle caution stance.
▶WEEK 8Mar 9$109,877.04
BUY NEM — Rebalance NEM from ~36.81% to 40.00% target weight per allocation output.
▶WEEK 7Mar 2$115,714.29
SELL B — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL COP — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL DVN — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL GILD — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL JNJ — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL PG — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL SHEL — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
SELL ZTS — Not in target allocation; exit position to fund NEM and raise cash buffer per macro guidance
BUY NEM — Initiate NEM position per approved buy list; tool-derived target weight 40% (max-cap constrained) while maintaining elevated cash posture
▶WEEK 6Feb 23$113,955.13
SELL COP x26 — Reduce COP exposure to align with 8.2% target weight while maintaining Energy tilt under late-cycle caution.
SELL JNJ x11 — Trim JNJ to align with 8.2% target weight per de-risk/profit-take guidance into dense macro calendar.
SELL MRK — Exit MRK as it is not in the approved 8-position target portfolio after allocation constraints were applied.
BUY DVN — Initiate DVN at 8.2% target weight to add Energy/value exposure while maintaining 18% cash buffer.
BUY SHEL — Initiate SHEL at 8.2% target weight to diversify Energy exposure per late-cycle/value-rotation posture.
BUY B — Increase B to 12.3% target weight as part of the rebalanced 8-position portfolio at 82% invested.
BUY GILD — Increase GILD to 12.3% target weight to maintain defensive healthcare exposure within the constrained target portfolio.
BUY PG — Increase PG to 12.3% target weight as defensive ballast consistent with late-cycle caution stance.
BUY ZTS — Increase ZTS to 12.3% target weight to maintain quality healthcare exposure in the target allocation.
▶WEEK 5Feb 17$112,467.15
SELL B x396 — Rebalance to target allocation (reduce B exposure to ~10.71% while maintaining 25% cash target).
SELL COP x173 — Rebalance to target allocation (reduce COP exposure to ~10.71%) consistent with risk-off defensive stance.
SELL MRK x160 — Rebalance to target allocation (reduce MRK exposure to ~10.71%) while retaining core defensive healthcare holding.
BUY ZTS — Initiate new defensive healthcare position to target weight (~10.71%) within 75% invested / 25% cash framework.
BUY PG — Initiate defensive consumer staples position to target weight (~10.71%) aligned with risk-off regime.
BUY JNJ — Initiate defensive healthcare position to target weight (~10.71%) while maintaining elevated cash buffer.
BUY GILD — Initiate defensive healthcare position to target weight (~10.71%) consistent with risk-off defensive allocation.
▶WEEK 4Feb 9$112,060.14
SELL GILD — Not in target portfolio - full exit
SELL MRK x123 — Reducing position to target portfolio weight
BUY B — Initiate new position to target portfolio weight
BUY COP — Initiate new position to target portfolio weight
▶WEEK 3Feb 2$107,384.47
SELL GILD x1 — Rebalance to target 40% weight and maintain ~20% cash target.
SELL MRK x4 — Rebalance to target 40% weight and maintain ~20% cash target.
▶WEEK 2Jan 26$103,678.64
BUY MRK — Rebalance to target allocation: increase MRK from current weight to 40% target while maintaining elevated cash (allocation tool output implies ~20% cash due to position caps).
▶WEEK 1Jan 20$100,000.00
BUY MRK — Initiate new position to reach target allocation (37.5%) while maintaining 25% cash target.
BUY GILD — Initiate new position to reach target allocation (37.5%) while maintaining 25% cash target.